|
Aug 26
|
Masimo SET® Pulse Oximetry: Superior Performance, Worldwide Presence, Immeasurable Impact
|
|
Aug 19
|
Masimo (MASI) Gets New Suitors for Its Consumer Business Sale
|
|
Aug 15
|
Accuray's (ARAY) Radixact for Cancer Treatment Debuts in US
|
|
Aug 15
|
Masimo is Executing a Successful Strategy to Deliver Long-Term, Sustainable Growth
|
|
Aug 15
|
Masimo's (MASI) W1 Watch Gains FDA Nod for SafetyNet Connectivity
|
|
Jul 29
|
New Study Finds That Remote Patient Monitoring with Masimo SafetyNet® Significantly Reduced Rates of Hospital Readmission and ED Visits for Patients Recuperating at Home After Joint Replacement Surgery
|
|
Jul 24
|
Masimo to Report Second Quarter 2024 Financial Results After Market Close on Tuesday, August 6
|
|
Jun 28
|
Masimo (MASI), Cleveland Clinic Unite to Enhance Patient Care
|
|
Jun 28
|
Cleveland Clinic and Masimo partner to improve remote patient monitoring
|
|
Jun 28
|
3 Medical Instruments Picks to Navigate Industry Challenges
|
|
Jun 27
|
Masimo and Cleveland Clinic Collaborate to Improve Hospital Remote Care
|
|
Jun 26
|
Masimo Files Investor Presentation Highlighting Innovation-Driven Value, Strategic Initiatives to Deliver Robust Growth and Margin Expansion and Risks of Ceding Control to Politan
|
|
Jun 26
|
Politan Details Why a Truly Independent Board is Urgently Needed at Masimo in Order to Protect Shareholder Value and Realize the Company’s Full Potential
|
|
Jun 20
|
Masimo Provides Facts in Response to Politan’s False Narrative
|
|
May 10
|
Masimo offers Politan a concession to avoid second proxy fight
|
|
May 9
|
UPDATE 4-Masimo prepared to provide one board seat if activist Politan drops proxy contest
|
|
May 9
|
Masimo First Quarter 2024 Earnings: Beats Expectations
|
|
May 8
|
Masimo Corporation (NASDAQ:MASI) Q1 2024 Earnings Call Transcript
|
|
May 8
|
Masimo (MASI) Q1 Earnings Beat Estimates, '24 EPS View Up
|
|
May 8
|
Apple is a formidable opponent. That hasn’t stopped this CEO from suing the tech giant
|